Atlas Trials

Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma

Clinical trial NCT04234022 · RECRUITING

Trial details

NCT number
NCT04234022
Sponsor
The Royal Wolverhampton Hospitals NHS Trust
Status
RECRUITING
Study type
OBSERVATIONAL
Multiple Myeloma
Start date
2021-10-22
Primary completion
2027-12-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.